Echocardiography- an effective tool for risk assessment of COVID-19 patients

Transthoracic echocardiography (TTE) might be a useful tool in risk stratification of patients with COVID-19, suggests a recent study published in the European Journal of Clinical Investigation.
Coronavirus disease 2019 (COVID-19) is a recently recognized viral infective disease which can be complicated by acute respiratory stress syndrome (ARDS) and cardiovascular complications including severe arrhythmias, acute coronary syndromes, myocarditis and pulmonary embolism.
Angelo Silverio et al. from the Department of Medicine, Surgery and Dentistry, University of Salerno, Baronissi, Italyaimed to identify the clinical conditions and echocardiographic parameters associated with in-hospital mortality in COVID-19.
The researchers carried out a multicentre retrospective observational study including seven Italian centres. Patients hospitalized with COVID-19 were included into study population. The association between baseline variables and risk of in-hospital mortality was assessed through multivariable logistic regression and competing risk analyses.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.